Companies
Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.
We deliver high-quality, affordable healthcare to employees through text. Employers cut 10–20% of healthcare spend. Employees get concierge care they love. Our AI-enabled virtual care treats common conditions over text or video. For in-person care, our AI agents search across all in-network providers using millions of price and quality data points, recommend the best options, then coordinate scheduling. Employees get rewarded for choosing high-value care through copay reimbursements. We've already contracted to roll out to thousands of employees across multiple employers for the 2025-2026 plan year. We're on a mission to build member-aligned, AI-native health insurance, starting with cost containment.
Ruth Health treats the 83% of post-pregnancy womxn who pee in their pants. We deliver 30-minute Postpartum Recovery + Training Sessions via telehealth, so moms around the globe with pelvic floor prolapse can get back to work, sex, and normal life—5x faster. Using conversational AI + biometric readings, Ruth Health will accumulate the largest, most diverse database in America on longitudinal maternal health
SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a phase 1b clinical trial in psoriasis, and human data in pancreatic cancer, uveitis and NASH. we have a total of 9 drugs in our pipeline and 15 patents.
Saatvy is a transparent, personalized and natural wellness platform to manage chronic conditions such as gut/sleep disorder, diabetes, arthritis, and postpartum thyroiditis. We do this by personalizing the health plans which are created by experienced and authentic Ayurveda practitioners. Several people in the USA have trusted us with their natural wellness journeys. The biggest benefit our customers find in the first consultation is understanding the root causes of their health issues, where traditional medicine often falls short. Our Ayurvedic practitioners have decades of experience, with some serving on Ayurveda boards in the USA.
38 million people suffer from heart rhythm disorders and are recommended to start medications that can save their lives, but require rigorous ECG monitoring to start and remain on these pills. SafeBeat Rx moves beyond diagnostics to guide these therapeutics, powered by our ML ECG software that integrates with existing FDA-cleared wearables to allow seamless physician approval of drug dosing, all from a mobile phone. We are a team of physicians, engineers, data scientists, and machine learning experts dedicated to using engineering to improve heart health.
Saffron Health is building AI agents that automate specialist referrals for primary care. Primary care staff spend hours each day on tedious coordination work: searching for in-network specialists, filling out authorization forms, and chasing down medical records. Saffron's agents find available in-network providers, complete prior authorizations, and help patients book appointments, which lowers administrative costs and improves access to care.
Sample transforms healthcare operations from a burden into a competitive advantage. Our users build copilots in Sample to support processes like patient intake and reimbursement. These copilots don't just speed up work – they capture valuable ground-truth data that make our models smarter over time. We work with leading national providers, already have data from 76% of US oncology clinics, and our network is rapidly expanding across the nation.
Sanvivo builds a multisided platform to enable customers to order medications, get pharmaceutical advice, and book health services at local pharmacies in Europe. Just like Shopify for pharmacies. Sanvivo gives pharmacies software to take, fill and schedule delivery for online orders. We also bring instant demand through integrations with 3rd party consumer delivery companies. Almost all pharmacies in Europe are, by law, local 1-person businesses. And they are not ready for online orders. Regulatory changes require pharmacies to take and fill e-prescriptions (roll-out Jan-23), but many have no way to do this online today. Sanvivo uses technology to give local pharmacies digital superpowers, enabling them to combine fast supply and high-quality consultation with state of the are e-commerce solutions.
SaveIN connects people with quality healthcare practices near them and enables them to split their entire medical and wellness bills into monthly instalments. Over 80% of healthcare expense in India is borne out of pocket since less than 10% of Indians have private health insurance. On top of this medical inflation is 15% per annum, thereby making paying for private care expensive and frictional. 5000+ healthcare practices in India now use SaveIN to be discovered by millions of high intent customers near them and offer instant, monthly payment plans for all healthcare services, thereby making it a win-win proposition for all.
Scanwell Health makes healthcare more accessible through smartphone-enabled, at-home diagnostics. Scanwell's innovative approach lets people test from anywhere, skip the waiting room and get same-day results. By quickly diagnosing acute illnesses, chronic diseases and rare conditions, Scanwell accelerates the path to treatment. Our first product is the only FDA-cleared over-the-counter app that provides testing and treatment for urinary tract infections (UTIs).
Science Exchange powers R&D outsourcing for the world’s top life sciences companies. Our marketplace gives scientists access to the innovation and research they need and our platform fully automates R&D outsourcing from source to pay so scientists can focus on what they love—science.
Digital health holds a lot of potential but is ignoring a growing problem: diagnostic testing. Without this data, providers and organizations will be limited in the services they can provide patients at home. Scout has developed a platform - Hub, test kits, and app - that delivers health testing at home with 10x lower development cost and 3x lower per-test price. Our patented tech also meets performance requirements for medical diagnoses and integrates with the current healthcare tech stack. Scout’s technology is poised to disrupt the outdated $33Bn diagnostic market by democratizing testing while dramatically improving the patient experience. Scout has received $16M in non-dilutive funding from the NIH and other organizations to fully de-risk our platform, and our pipeline includes a diverse test menu for primary care (e.g. respiratory and sexual health), wellness (e.g. gut health), and chronic conditions (e.g. certain cancers). We have already received FDA authorization for our platform in clinical settings and are planning to launch our flagship Scout Hub in 2024.
Segmed provides at-scale access to novel clinical data globally, offering millions of diagnostic-grade medical images to accelerate innovation and mature the evidence needs of life sciences and technology industry. Our solutions allow you to access a Real World Data (RWD) network to facilitate rapid discovery and investigational capability of imaging data, development of early disease detection & prediction models, improved patient recruitment and reduced operating burden to access therapeutic data ecosystem.
SelectIQ addresses the primary bottleneck in drug development: recruiting patients into clinical trials. We analyze electronic health records to help doctors find clinical trials for their patients, and to help trial sites find patients for their studies. 72% of doctors want to inform their patients of clinical trials, but only 5% do. We're on a mission to close that gap, ultimately bringing safer, more effective drugs to the patients who need them.
Heart failure impacts millions worldwide and is associated with poor quality of life and high mortality rates. Because the heart cannot pump efficiently, fluids buildup around the body. Fluid overload is the main driver behind patient symptoms (shortness of breath, fatigue, chest pain, etc.) and hospitalizations. Our minimally invasive device leverages the body's innate fluid management system to offload trapped fluid and prevent subsequent rounds of buildup. The one-time procedure has sustained effect -- keeping patients healthier, happier, and out of the hospital.
Selia Connects individuals and certified psychologists and psychiatrists with an online platform for one-on-one therapy delivered via video call. Selia offers convenient and affordable access to a fully-credentialed network of highly qualified providers while giving individuals self-guided tools, journaling and mood tracking to help them achieve their goals. We created Selia to address the unmet and growing demand for mental health services for Spanish speaking Latam everywhere. Our business-to-consumer (“B2C”) channel, made of individual consumers who pay directly to our platform, and our business-to-business (“B2B”) channel, that consist from start ups to enterprise clients such as Experian, Starbucks, Habi and more
The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.
